A PHASE IIB, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, DOSE-RANGING STUDY TO ASSESS THE EFFICACY AND SAFETY OF MSTT1041A IN PATIENTS WITH UNCONTROLLED SEVERE ASTHMA

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2017
This article has no abstract
Epistemonikos ID: 35121c15fbeea611c760ff626f404adbbb1e8c63
First added on: Apr 16, 2025